Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $187,435 - $311,411
-5,661 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$50.07 - $66.05 $16,523 - $21,796
-330 Reduced 5.51%
5,661 $284,000
Q2 2021

Aug 09, 2021

SELL
$56.61 - $80.46 $849 - $1,206
-15 Reduced 0.25%
5,991 $378,000
Q1 2021

May 05, 2021

SELL
$86.23 - $125.19 $111,667 - $162,121
-1,295 Reduced 17.74%
6,006 $558,000
Q4 2020

Feb 09, 2021

BUY
$79.17 - $111.47 $128,651 - $181,138
1,625 Added 28.63%
7,301 $654,000
Q3 2020

Nov 06, 2020

BUY
$81.91 - $134.94 $83,875 - $138,178
1,024 Added 22.01%
5,676 $586,000
Q2 2020

Aug 07, 2020

BUY
$54.33 - $89.52 $252,743 - $416,447
4,652 New
4,652 $368,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $539M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.